Trial Profile
Double-blind, Placebo-controlled Randomised Study on the Efficacy of Naloxone Nasal Spray for the Treatment of Gambling Disorder
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 05 Jul 2021
Price :
$35
*
At a glance
- Drugs Naloxone (Primary)
- Indications Gambling
- Focus Therapeutic Use
- Acronyms NalGamb
- 05 Jul 2021 According to ClinicalTrials.gov, the recruitment status of this study is unknown because the information has not been verified recently (last verified Jul 2019).
- 23 Oct 2019 Status changed from recruiting to completed.
- 14 Jul 2019 Planned End Date changed from 30 Mar 2019 to 30 Mar 2020.